open label,single arm clinical study to evaluate the efficacy and safety of unani pharmacopoeial formulation -Majun Zanjabeel in kasrat-e-Tams(Heavy menstrual Bleeding)

Central Council for Research in Unani Medicine0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Non Gravid females of reproductive age
•patients with menorrhagia as indicated by
•i) Excessive menstrual loss greater than 80 ml per cycle as calculated by menstrual pictogram
•ii) Menstrual cycle greater than 6 days

•1. Heavy Menstrual Bleeding with structural or histological abnormality with symptoms such as Intermenstrual or post coital bleeding pelvic pain and or pressure symptoms
•2. Patients presenting with Heavy Menstrual Bleeding since menoarche
•Patients with a personal or family history suggesting a coagulation disorder
•Patients using Intrauterine Contraceptive Devices
•Patients with illness requiring long term treatment e.g Hypertension TB etc
•Patients with Post-menopausal bleeding
•Patients with HMB taking Hormone Replacement Therapy
•Conditions where HBM is not the main presenting menstrual symptom eg endometriosis
•Pregnant and lactating females

发起方